Physician
Peoria Tazewell Pathology Group, S.C.
Peoria Tazewell Pathology Group, S.C. was paid $1.06M by Medicaid between May 2018 and Dec 2024, across 79 billing codes. Its largest line is 0202U, Oncology (prostate), multianalyte, gene expression profiling — 53% of everything it billed.
33Billing provider infoPEORIA TAZEWELL PATHOLOGY GROUP, S.C.
PEORIA, IL 61603
PEORIA, IL 61603
33aNPI1578597738assigned 07/11/2006
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$1.06M
24GClaims65,612
24DCodes billed79
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in Illinois
Rank by total paid#62 of 398
Median peer was paid$66K
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14 | $239.74 | |
| 2019 | 231 | $10K | |
| 2020 | 324 | $27K | |
| 2021 | 2,764 | $565K | |
| 2022 | 3,170 | $232K | |
| 2023 | 6,280 | $117K | |
| 2024incomplete | 52,829 | $107K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 53% | 1,616 | 1,557 | $558K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 33% | 6,763 | 6,453 | $349K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 7.7% | 1,314 | 1,280 | $81K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.5% | 686 | 643 | $37K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.9% | 1,707 | 1,433 | $20K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 229 | 228 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 241 | 220 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,580 | 1,552 | $1K |
| 80053 | Comprehensive metabolic panel | <1% | 7,255 | 5,843 | $807.15 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,187 | 4,815 | $576.48 |
| 88141 | <1% | 26 | 26 | $434.28 | |
| 88304 | <1% | 18 | 13 | $354.00 |
67 more codes
| 84484 | <1% | 1,526 | $140.93 | |
| 85027 | <1% | 4,182 | $74.51 | |
| 87040 | <1% | 495 | $58.68 | |
| 84702 | <1% | 479 | $42.76 | |
| 80061 | Lipid panel | <1% | 1,066 | $41.51 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,031 | $34.28 |
| 83605 | <1% | 1,079 | $30.36 | |
| 87186 | <1% | 200 | $28.86 | |
| 83690 | <1% | 2,126 | $25.96 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 732 | $20.22 |
| 83735 | <1% | 2,682 | $19.53 | |
| 86140 | <1% | 960 | $17.60 | |
| 86803 | <1% | 360 | $16.22 | |
| 85610 | <1% | 725 | $14.91 | |
| 82962 | <1% | 2,412 | $14.13 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 338 | $11.52 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 405 | $11.46 |
| 85730 | <1% | 196 | $7.40 | |
| 81003 | <1% | 1,991 | $7.14 | |
| 86850 | <1% | 474 | $6.57 | |
| 84439 | <1% | 295 | $6.54 | |
| 81001 | <1% | 1,737 | $5.97 | |
| 86900 | <1% | 569 | $4.23 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 183 | $4.05 |
| 86901 | <1% | 578 | $3.93 | |
| 84703 | <1% | 562 | $3.78 | |
| 81025 | <1% | 785 | $1.62 | |
| 86593 | <1% | 481 | $0.78 | |
| 87077 | 0% | 265 | $0.00 | |
| 83880 | 0% | 262 | $0.00 | |
| 85652 | 0% | 292 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 642 | $0.00 |
| 86738 | 0% | 144 | $0.00 | |
| 85379 | 0% | 432 | $0.00 | |
| 87070 | 0% | 121 | $0.00 | |
| 87205 | 0% | 107 | $0.00 | |
| 82728 | 0% | 259 | $0.00 | |
| 87081 | 0% | 26 | $0.00 | |
| 82803 | 0% | 693 | $0.00 | |
| 82077 | 0% | 1,147 | $0.00 | |
| 82607 | 0% | 228 | $0.00 | |
| 82550 | 0% | 165 | $0.00 | |
| 87340 | 0% | 87 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 176 | $0.00 |
| 82746 | 0% | 122 | $0.00 | |
| 86706 | 0% | 32 | $0.00 | |
| 84153 | 0% | 13 | $0.00 | |
| 83550 | 0% | 179 | $0.00 | |
| 82950 | 0% | 71 | $0.00 | |
| 86762 | 0% | 26 | $0.00 | |
| 86704 | 0% | 14 | $0.00 | |
| 80179 | 0% | 177 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 176 | $0.00 |
| 80143 | 0% | 599 | $0.00 | |
| 87210 | 0% | 69 | $0.00 | |
| 84156 | 0% | 142 | $0.00 | |
| 82570 | 0% | 281 | $0.00 | |
| 84145 | 0% | 210 | $0.00 | |
| 85007 | 0% | 391 | $0.00 | |
| 84100 | 0% | 359 | $0.00 | |
| 80074 | 0% | 12 | $0.00 | |
| 80076 | 0% | 57 | $0.00 | |
| 83540 | 0% | 205 | $0.00 | |
| 87641 | 0% | 61 | $0.00 | |
| 86038 | 0% | 29 | $0.00 | |
| 82565 | 0% | 37 | $0.00 | |
| 82010 | 0% | 33 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHAMPAGNE, RONALD (PRESIDENT)